Elevated plasma 4-pyridoxic acid in renal insufficiency

American Journal of Clinical Nutrition

Volumn 75, Issue 1, 2002, Pages 57-64

  Coburn, Stephen P ^a,b,c,d,e,f   Reynolds, Robert D ^a,b,c,d,e,f   Mahuren, J Dennis ^a,b,c,d,e,f   Schaltenbrand, Wayne E ^a,b,c,d,e,f   Wang, Yao ^a,b,c,d,e,f   Ericson, Karen L ^a,b,c,d,e,f   Whyte, Michael P ^a,b,c,d,e,f   Zubovic, Yvonne M ^a,b,c,d,e,f   Ziegler, Paula J ^a,b,c,d,e,f   Costill, David L ^a,b,c,d,e,f   Fink, William J ^a,b,c,d,e,f   Pearson, David R ^a,b,c,d,e,f   Pauly, Thomas A ^a,b,c,d,e,f   Thampy, K George ^a,b,c,d,e,f   Wortsman, Jacobo ^a,b,c,d,e,f  

^a Fort Wayne State Developmental Center   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d Department of Mathematical Sciences ^*  (United States)

^e BALL STATE UNIVERSITY   (United States)

^f SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 Pyridoxic acid; Lactation; Pregnancy; Pyridoxal; Pyridoxal P; Renal function; Vitamin B 6; Women

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; PYRIDOXIC ACID; PYRIDOXINE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIETARY INTAKE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOPHOSPHATASIA; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; LACTATION; PREGNANCY; STATISTICAL ANALYSIS; VITAMIN METABOLISM;

EID: 18244379873     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/75.1.57     Document Type: Article

References (41)

1. Vitamin B-6 deficiency in maintenance dialysis patients: Metabolic effects of repletion
2. Renal lesions in pyridoxine deficient rats
3. Vitamin B-6 deficiency and renal function and structure in chronically uremic rats
4. The effects of an induced pyridoxine deficiency and pantothenic acid deficiency on excretions of oxalic and xanthurenic acids in urine
5. Oral pyridoxine in the prevention of oxalate kidney stones
6. Hyperoxaluria in idiopathic oxalate nephrolithiasis
7. Effect of vitamin B-6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients
8. Intake of vitamins B6 and C and the risk of kidney stones in women
9. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men
10. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
11. Effect of vitamin B-6 depletion on the pyridoxal, pyridoxamine and pyridoxine content of the blood and urine of men
12. Pyridoxine uptake by rat renal proximal tubular cells
13. Management of pyridoxine and pyridoxal in the isolated kidney of the rat
14. 6 by human kidney
15. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 and over
16. Determination of urinary 4-pyridoxic acid levels as 4-pyridoxic acid lactone using high performance liquid chromatography
17. Synthesis of deuterated vitamin B-6 compounds
18. Modeling short (7h)- and long (6wk)-term kinetics of vitamin B-6 metabolism with stable isotopes in humans
19. Response of vitamin-B-6 content of muscle to changes in vitamin B-6 intake in men
20. Pyridoxic acid excretion during low vitamin B-6 intake, total fasting, and bed rest
21. Markedly increased circulating pyridoxal 5′-phosphate levels in hypophosphatasia
22. B-6 vitamers: Cation exchange HPLC
23. EMSA: A SAAM service for the estimation of population parameters based on model fits to identically replicated experiments
24. Modeling vitamin B-6 metabolism
25. Receiver-operating characteristics (ROC) plots: A fundamental evaluation tool in clinical medicine
26. Pregnancy and the kidney
27. Alkaline phosphatase: Placental and tissue nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate (substrate accumulation in carriers of hypophosphatasia corrects during pregnancy)
28. A new perspective in the assessment of vitamin B-6 nutritional status during pregnancy in humans
29. Vitamin B-6 status indices are lower in pregnant than in nonpregnant women but urinary excretion of 4-pyridoxic acid does not differ
30. The utilization of intravenously infused pyridoxine in humans
31. Pharmacokinetic properties of the plasma B-6 vitamers after single and chronic oral pyridoxine mega doses
32. Metabolism of vitamin B-6 by human liver
33. Can dietary supplements with folic acid or vitamin B-6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease
34. Phosphorylation of pyridoxine by human blood platelets-effects of structure analogs and metabolic inhibitors
35. Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate
36. The enzymatic oxidation of pyridoxine and pyridoxamine phosphates
37. 4-Pyridoxic acid 5′-phosphate: A metabolite of pyridoxal in the rat
38. Regarding 4-pyridoxic acid 5′-phosphate in animal tissue
39. Transport and metabolism of pyridoxine in rat liver